VLI Research Inc is dedicated to understanding ubiquitin proteasome system (UPS) and its role in disease. To that end we have developed technologies to discover drugs that targets UPS by Protein Targeting Chimera (PROTAC) and molecular glue mechanisms. Our mission is to ensure that our clients can trust the quality of products and services with confidence.
Our team of highly trained life sciences Ph.D and other staff have years of experience in drug discovery and diagnostics. We provide top-quality research services and are committed to adapting current technology and techniques in UPS drug discovery.
Our state-of-the-art facilities are equipped with the latest protein expression purifications, assay development, high throughput screening from large chemical libraries, medicinal chemistry and mass spec proteomics equipment and technologies. This allows us to provide accurate and reliable results for our clients. We maintain a clean and safe environment to ensure the integrity of our testing processes.
Copyright © 2024 VLI-Research - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.